BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21814484)

  • 1. Long-term cultured human neural stem cells undergo spontaneous transformation to tumor-initiating cells.
    Wu W; He Q; Li X; Zhang X; Lu A; Ge R; Zhen H; Chang AE; Li Q; Shen L
    Int J Biol Sci; 2011; 7(6):892-901. PubMed ID: 21814484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenografts.
    Johnson H; Del Rosario AM; Bryson BD; Schroeder MA; Sarkaria JN; White FM
    Mol Cell Proteomics; 2012 Dec; 11(12):1724-40. PubMed ID: 22964225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma.
    Shiras A; Chettiar ST; Shepal V; Rajendran G; Prasad GR; Shastry P
    Stem Cells; 2007 Jun; 25(6):1478-89. PubMed ID: 17332509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crizotinib and erlotinib inhibits growth of c-Met
    Goodwin CR; Rath P; Oyinlade O; Lopez H; Mughal S; Xia S; Li Y; Kaur H; Zhou X; Ahmed AK; Ho S; Olivi A; Lal B
    Clin Neurol Neurosurg; 2018 Aug; 171():26-33. PubMed ID: 29803091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phenotype of SHG-44 glioma stem cell spheres and pathological characteristics of their xenograft tumors].
    Wu TF; Chen JM; Chen SS; Chen GL; Wei YX; Xie XS; Du ZW; Zhou YX
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):726-31. PubMed ID: 24378091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors.
    Li L; Dutra A; Pak E; Labrie JE; Gerstein RM; Pandolfi PP; Recht LD; Ross AH
    Neuro Oncol; 2009 Feb; 11(1):9-21. PubMed ID: 18812521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
    Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
    Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.
    Giannini C; Sarkaria JN; Saito A; Uhm JH; Galanis E; Carlson BL; Schroeder MA; James CD
    Neuro Oncol; 2005 Apr; 7(2):164-76. PubMed ID: 15831234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.
    Nishikawa R; Ji XD; Harmon RC; Lazar CS; Gill GN; Cavenee WK; Huang HJ
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7727-31. PubMed ID: 8052651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene.
    Johns TG; Stockert E; Ritter G; Jungbluth AA; Huang HJ; Cavenee WK; Smyth FE; Hall CM; Watson N; Nice EC; Gullick WJ; Old LJ; Burgess AW; Scott AM
    Int J Cancer; 2002 Mar; 98(3):398-408. PubMed ID: 11920591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioblastoma stem-like cell lines with either maintenance or loss of high-level EGFR amplification, generated via modulation of ligand concentration.
    Schulte A; Günther HS; Martens T; Zapf S; Riethdorf S; Wülfing C; Stoupiec M; Westphal M; Lamszus K
    Clin Cancer Res; 2012 Apr; 18(7):1901-13. PubMed ID: 22316604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor.
    Takasu S; Takahashi T; Okamoto S; Oriuchi N; Nakayashiki N; Okamoto K; Muramatsu H; Hayashi T; Nakahara N; Mizuno M; Wakabayashi T; Higuchi T; Endo K; Kozaki K; Miyaishi O; Saga S; Ueda R; Yoshida J; Yoshikawa K
    J Neurooncol; 2003 Jul; 63(3):247-56. PubMed ID: 12892230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-146a inhibits glioma development by targeting Notch1.
    Mei J; Bachoo R; Zhang CL
    Mol Cell Biol; 2011 Sep; 31(17):3584-92. PubMed ID: 21730286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes.
    Lo HW; Cao X; Zhu H; Ali-Osman F
    Mol Cancer Res; 2010 Feb; 8(2):232-45. PubMed ID: 20145033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cells in nervous system tumors.
    Singh SK; Clarke ID; Hide T; Dirks PB
    Oncogene; 2004 Sep; 23(43):7267-73. PubMed ID: 15378086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor variant III contributes to cancer stem cell phenotypes in invasive breast carcinoma.
    Del Vecchio CA; Jensen KC; Nitta RT; Shain AH; Giacomini CP; Wong AJ
    Cancer Res; 2012 May; 72(10):2657-71. PubMed ID: 22419663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GBM secretome induces transient transformation of human neural precursor cells.
    Venugopal C; Wang XS; Manoranjan B; McFarlane N; Nolte S; Li M; Murty N; Siu KW; Singh SK
    J Neurooncol; 2012 Sep; 109(3):457-66. PubMed ID: 22752853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
    Di K; Linskey ME; Bota DA
    Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of stemness in primary retinoblastoma cells by analysis of stem-cell phenotypes and tumorigenicity with culture and xenograft models.
    Tang Z; Ma H; Mao Y; Ai S; Zhang P; Nie C; Gao Y; Lu R
    Exp Cell Res; 2019 Jun; 379(1):110-118. PubMed ID: 30935947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma extracellular vesicles induce the tumour-promoting transformation of neural stem cells.
    Wang J; Liu J; Sun G; Meng H; Wang J; Guan Y; Yin Y; Zhao Z; Dong X; Yin S; Li H; Cheng Y; Wu H; Wu A; Yu X; Chen L
    Cancer Lett; 2019 Dec; 466():1-12. PubMed ID: 31521694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.